Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Clinical trial NCT04518306 · COMPLETED
Trial details
- NCT number
- NCT04518306
- Sponsor
- George Medicines PTY Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-14
- Primary completion
- 2023-09-19
- Enrollment
- 755
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.